Product Name | MF | CAS | Details |
---|
Naproxen | C14H14O3 | 22204-53-1 | Details |
4-(4-Chlorophenyl)-4-hydroxypiperidine | C11H14ClNO | 39512-49-7 | Details |
Triethyl phosphonoacetate | C8H17O5P | 867-13-0 | Details |
Eribulin (Available for selected markets) | C40H59NO11 | 253128-41-5 | Details |
Abemaciclib | C27H32F2N8 | 1231929-97-7 | Details |
Ketorolac Tromethamine | C19H24N2O6 | 74103-07-4 | Details |
Naproxen Sodium | C14H13O3.Na | 26159-34-2 | Details |
Apremilast (Amorphous and Form B) | C22H24N2O7S | 608141-41-9 | Details |
Cabozantinib S-Malate | C32H30FN3O10 | 1140909-48-3 | Details |
Entrectinib | C31H34F2N6O2 | 1108743-60-7 | Details |
N-(3-Hydroxypheny)cinnamamide | C15H13NO2 | 23478-25-3 | Details |
Naratriptan | C17H25N3O2S | 121679-13-8 | Details |
Tucatinib | C26H24N8O2 | 937263-43-9 | Details |
2-(azidomethyl)-1,3-difluorobenzene | C7H5F2N3 | 106308-60-5 | Details |
4-(2-methylproxy)-benzenemethanamine | C13H20ClFN2 | 1837794-51-0 | Details |
Palonosetron Hydrochloride | C19H25ClN2O | 135729-62-3 | Details |
Eliglustat Hemitartrate | C50H78N4O14 | 928659-70-5 | Details |
1-(2-ethoxyethyl)-2-(piperidin-4-yl)]-1H-benzo[d]imida-zole | C7H12O2 | 63095-51-2 | Details |
Bortezomib | C19H25BN4O4 | 179324-69-7 | Details |
Travoprost | C26H35F3O6 | 157283-68-6 | Details |
Capecitabine | C15H22FN3O6 | 166806-48-6 | Details |
Pazopanib | C21H23N7O2S | 444731-52-6 | Details |
Dutasteride - Form 2 | C27H30F6N2O2 | 164656-23-9 | Details |
Cetirizine Dihydrochloride | C21H26Cl2N2O3 | 83881-52-1 | Details |
1-(1-Chloroethyl)-2,3-dimethylbenzene | C10H13Cl | 60907-88-2 | Details |
Bendamustine Hydrochloride | C16H22Cl3N3O2 | 3543-75-7 | Details |
Tirzepatide | C???H???N??O??Cl | 2023788-19-2 | Details |
Etrasimod | C26H26F3NO3 | 1206123-37-6 | Details |
Naratriptan Hydrochloride | C17H25N3O2S.ClH | 143388-64-1 | Details |
Sumatriptan Succinate | C18H27N3O6S | 103628-48-4 | Details |
Dasatinib Monohydrate | C22H28ClN7O3S | 332781-69-2 | Details |
Fezolinetant | C16H15FN6OS | 1629229-37-3 | Details |
Osimertinib | C29H37N7O5S | 1421373-66-1 | Details |
N-Methyl Desloratadine | C20H21ClN2 | 38092-89-6 | Details |
Gemcitabine Hydrochloride | C9H11F2N3O4.ClH | 122111-03-9 | Details |
Elagolix Sodium | C32H29F5N3NaO5 | 832720-36-2 | Details |
Ondansetron Base | C18H19N3O | 116002-70-1 | Details |
Finerenone | C21H22N4O3 | 1050477-31-0 | Details |
Lomustine | C9H16ClN3O2 | 13010-47-4 | Details |
Olaparib - Form A | C24H23FN4O3 | 763113-22-0 | Details |
Levocetirizine Dihydrochloride | C21H27Cl3N2O3 | 130018-87-0 | Details |
4-Bromo-2,2-diphenybutyric acid | C16H15BrO2 | 37742-98-6 | Details |
Pemetrexed Disodium Heptahydrate | C20H24N5NaO7 | 357166-29-1 | Details |
Pomalidomide | C13H11N3O4 | 19171-19-8 | Details |
Acalabrutinib | C26H23N7O2 | 1420477-60-6 | Details |
Ritlecitinib | C15H19N5O | 1792180-81-4 | Details |
Cabozantinib HCL | C28H25ClFN3O5 | 1817759-42-4 | Details |
Lifitegrast | C29H24Cl2N2O7S | 1025967-78-5 | Details |
Montelukast | C35H36ClNO3S | 158966-92-8 | Details |
N-(4-fluorobenzy)-1-methypiperidin-4-amine.HCl | C7H6ClF | 456-42-8 | Details |
Ibrutinib (Form A) | C25H24N6O2 | 936563-96-1 | Details |
Brigatinib | C29H39ClN7O2P | 1197953-54-0 | Details |
3-(4-chlorophenyl)propan-1-ol | C9H11ClO | 6282-88-8 | Details |
(1S,5R)-1-Pheny-3-oxabicyclo[3.1.0]hexan-2-one | C11H10O2 | 96847-53-9 | Details |
Varenicline Tartrate | C17H19N3O6 | 375815-87-5 | Details |
Mirabegron | C21H24N4O2S | 223673-61-8 | Details |
Carfilzomib | C40H57N5O7 | 868540-17-4 | Details |
Niraparib Tosylate | C26H28N4O4S | 1038915-73-9 | Details |
Pirtobrutinib | C22H21F4N5O3 | 2101700-15-4 | Details |
Cinacalcet Hydrochloride | C22H23ClF3N | 364782-34-3 | Details |
Ribociclib | C23H30N8O | 1211441-98-3 | Details |
2-(1-Adamantyl)-4-BromoAnisole | C17H21BrO | 104224-63-7 | Details |
Enzalutamide | C21H16F4N4O2S | 915087-33-1 | Details |
Tofacitinib Citrate - Crystalline Form A | C16H20N6O.C6H8O7 | 540737-29-9 | Details |
Perfluorohexyloctane | C14H17F13 | 133331-77-8 | Details |
Cabazitaxel | C45H57NO14 | 183133-96-2 | Details |
Edoxaban | C24H30ClN7O4S | 480449-70-5 | Details |
Darolutamide | C19H19ClN6O2 | 1297538-32-9 | Details |
Fosaprepitant | C23H22F7N4O6P | 172673-20-0 | Details |
Ripretinib | C24H21BrFN5O2 | 1442472-39-0 | Details |
Decitabine | C8H12N4O4 | 2353-33-5 | Details |
Daprodustat | C19H27N3O6 | 960539-70-2 | Details |
Voclosporin | C63H111N11O12 | 515814-01-4 | Details |
Mavacamten | C15H19N3O2 | 1642288-47-8 | Details |
Adagrasib | C32H35ClFN7O2 | 2326521-71-3 | Details |
Zoledronic Acid | C5H10N2O7P2 | 118072-93-8 | Details |
Alectinib | C30H34N4O2 | 1256580-46-7 | Details |
Azacitidine | C8H12N4O5 | 320-67-2 | Details |
Lenvatinib Mesylate (Form C and MIBK Solvate) | C22H23ClN4O7S | 857890-39-2 | Details |
Permethrin | C21H20Cl2O3 | 52645-53-1 | Details |
Testosterone | C19H28O2 | 58-22-0 | Details |
Deucravacitinib | C20H22N8O3 | 1609392-27-9 | Details |
(2E)-N-(3-Methoxy-phenyl)-3-Phenyl-Acrylamide | C16H15NO2 | 15116-41-3 | Details |
Salcaprozpate Sodium (SNAC) (Excipient for Oral Semaglutide) | C15H22NNaO4 | 203787-91-1 | Details |
Granisteron | C18H24N4O | 109889-09-0 | Details |
Lenalidomide - Form A | C13H13N3O3 | 191732-72-6 | Details |
Mirogabalin Besylate | C18H25NO5S | 1138245-21-2 | Details |
N,N-diethy-1-methylpiperidine-4-carboxamide | C11H22N2O.HI | 6339-83-9 | Details |
Venetoclax | C45H50ClN7O7S | 1257044-40-8 | Details |
Midostaurin (Amorphous and Form II) | C35H30N4O4 | 120685-11-2 | Details |
Treprostinil Olamine | C15H13N3O4S. C2H7NO | 85056-47-9 | Details |
Fruquintinib | C21H19N3O5 | 1194506-26-7 | Details |
(1S.2R)-N,N-diethy1-2-(hydroxymethy)-1-phenyicyclop-ropane-carboxamide | C15H21NO2 | 172015-99-5 | Details |
Resmetirom | C17H12Cl2N6O4 | 920509-32-6 | Details |
Dabrafenib | C23H20F3N5O2S2 | 1195765-45-7 | Details |
3-Fluorobenzyl chloride | C14H11FO2 | 66742-57-2 | Details |
Tert-butyl[trans-4-(2-hydroxyethyl) cyclohexyl] carbamate | C13H23NO4 | 189153-10-4 | Details |
trans-(N-Boc-4-aminocyclohexyl)acetic Acid | C15H27NO4 | 946598-34-1 | Details |
Relugolix | C29H27F2N7O5S | 737789-87-6 | Details |
2-[(1E)-2-(2-Bromophenyl)vinyl]-4-chlorophenylacetate | C16H12BrClO2 | 1000890-04-9 | Details |
Product Total: Product Page: | ||||
1 2 3 |